International Psoriasis Council

Advancing Knowledge. Enhancing Care.

Advancing Knowledge. Enhancing Care.

Psoriasis News

THE LATEST FROM IPC, INDUSTRY, AND NEWS

Results
image of computer with words expert commentary

Mark Lebwohl COVID-19

Commentary from IPC Councilor Mark Lebwohl, MD, on a case series in NEJM on COVID-19 in immune-mediated inflammatory diseases.

Read More

Declaração sobre o surto de Coronavírus

Para pacientes com psoríase diagnosticados com doença causada pelo COVID-19, o IPC recomenda que médicos interrompam ou adiem o uso de medicamentos imunossupressores. Esta recomendação está em acordo com guias de tratamento já existentes (por exemplo, o European Dermatology Forum e a American Academy of Dermatology), que declaram que tratamentos imunossupressores são contraindicados em pacientes com infecções ativas.

Read More
image of computer with words expert commentary

Commentary: Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biological treatment and renal transplanted recipients in maintenance immunosuppressive treatment.

Prof. van de Kerkhof provides a review of a recent publication by Paulo Gisondi from Verona on the risk of hospitalization and death from COVID-19 in psoriatic patients receiving biological treatments (980 patients) and renal transplant recipients on immunosuppressive treatment (247 patients).

Read More

New Resources

Roflumilast – A Potential New First Line Systemic Drug for Psoriasis

Focus on Psoriasis: A Report from the European Academy of Dermatology and Venereology 31st Annual Congress (EADV)

La perspectiva del paciente

Subscribe to the IPC Newsletter

We believe that psoriasis patients, no matter where they live in the world, no matter how complex their symptoms, should have access to the best care available to them. Please join us in making this possible.